在早产婴儿中间歇性低氧化和脑损伤生物标志物S100B
Neonatology
|February 27, 2026
概括
尿中的S100B蛋白水平随着早产婴儿间歇性低氧化 (IH) 负担的增加而上升. 这种非侵入性生物标志物可能表明IH相关的大脑损伤,其模式因妊娠年龄而异.
科学领域:
- 新生儿医学 新生儿医学
- 神经科学是一个神经科学.
- 生物标志物 生物标志物
背景情况:
- 间歇性低氧症 (IH) 是早产婴儿中普遍存在的并发症,与不良的神经发育结果和脑损伤密切相关.
- S100B是一种来自质细胞的蛋白质,是神经损伤的早期指标,可以在尿液中非侵入性地检测到.
研究的目的:
- 调查间歇性低氧化症 (IH) 负担与早产婴儿尿中S100B水平之间的关联.
- 探索尿路S100B作为一种非侵入性生物标志物的潜力,用于在这个脆弱人群中检测IH相关的大脑损伤.
主要方法:
- 预期招募早产婴儿 (孕期≤32周) 进行持续的氧和监测.
- 使用经过验证的算法对IH资料进行量化,并通过超敏感免疫检测测量尿液S100B,将其正常化为肌素.
- 使用权重的斯皮尔曼相关性来分析IH指标和尿道S100B之间的关联,考虑妊娠年龄子组.
主要成果:
- 在更高的尿S100B水平和增加的IH频率,持续时间和严重程度 (较低的和值) 之间观察到显著的正相关性.
- 相关性强度因IH事件持续时间和婴儿妊娠年龄而异,较短的事件与频率/时间密切相关,较长的事件与最低点相关.
- 尿液S100B显示了IH负担的逐步增加,这表明了剂量-反应关系.
结论:
- 在早产婴儿中,尿液中的S100B水平升高,间歇性低氧化血的负担更高.
- 尿路S100B和IH指标之间的关系受到妊娠年龄和低血量事件的特征的影响.
- 尿液S100B成为有希望的非侵入性生物标志物,用于早期检测早产新生儿的IH相关脑损伤.
相关概念视频
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:25Secondary Spinal Cord Injury llI: Pathophysiology
Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...